Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats

Journal of Pharmacological Sciences

Volumn 110, Issue 2, 2009, Pages 160-168

  Mori, Asami ^a   Saigo, Orie ^a   Hanada, Masayuki ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Diabetes; Endothelium; Nitric oxide; Retinal hemodynamics

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ETHYL 2 (HYDROXYAMINO) 5 NITRO 3 HEXENAMIDE; FORSKOLIN; GLUCOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CAPILLARY FLOW; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; RAT; RETINA BLOOD VESSEL; RETINA CAPILLARY; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 67649671778     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08320FP     Document Type: Article

References (32)

1. Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, et al. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci. 1994;35:2968-2975. (Pubitemid 24186398)
2. Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV. From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab Rev. 1997;13:15-35. (Pubitemid 27213791)
3. De La Cruz JP, Gonzalez-Correa JA, Guerrero A, de la Cuesta FS. Pharmacological approach to diabetic retinopathy. Diabetes Metab Res Rev. 2004;20:91-113. (Pubitemid 38489659)
4. Nakazawa T, Kaneko Y, Mori A, Saito M, Sakamoto K, Nakahara T, et al. Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vascular Pharmacol. 2007;46:153-159. (Pubitemid 46096809)
5. Nakazawa T, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Vasodilator effects of adenosine on retinal arterioles in streptozotocin-induced diabetic rats. Naunyn-Schmiedeberg's Arch Pharmacol. 2008;376:423-430.
6. Sakamoto K, Kuwagata M, Nakahara T, Ishii K. Late preconditioning in rat retina: involvement of adenosine and ATP-sensitive K+ channel. Eur J Pharmacol. 2001;418:89-93. (Pubitemid 32378814)
7. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 1986;132:75-78. (Pubitemid 17229974)
8. Taylor PD, McCarthy AL, Thomas CR, Poston L. Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br J Pharmacol. 1992;107:393-399.
9. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-974. (Pubitemid 30453529)
10. Benedito S, Prieto D, Nielsen PJ, Nyborg NC. Role of the endothelium in acetylcholine-induced relaxation and spontaneous tone of bovine isolated retinal small arteries. Exp Eye Res. 1991;52:575-579.
11. Yu PK, Yu DY, Cringle SJ, Su EN. Tetrahydrobiopterin reverses the impairment of acetylcholine-induced vasodilatation in diabetic ocular microvasculature. J Ocul Pharmacol Ther. 2001;17:123-129. (Pubitemid 32299077)
12. Chung SS, Chung SK. Aldose reductase in diabetic microvascular complications. Curr Drug Targets. 2005;6:475-486. (Pubitemid 40921713)
13. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55:498-510. (Pubitemid 46962309)
14. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103.
15. Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2005;1:93-106.
16. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396:269-272. (Pubitemid 28541391)
17. Edwards G, Feletou M, Gardener MJ, Thollon C, Vanhoutte PM, Weston AH. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol. 1999;128:1788-1794. (Pubitemid 30011893)
18. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423. (Pubitemid 26072547)
19. Campbell WB, Harder DR. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res. 1999;84:484-488. (Pubitemid 29120015)
20. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000;106:1521-1530. (Pubitemid 32040953)
21. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium- derived hyperpolarizing factor. Pharmacol Res. 2004; 49:543-549. (Pubitemid 38338664)
22. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A. 2003;100:1426-1431. (Pubitemid 36184018)
23. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res. 2002;90:1108-1113. (Pubitemid 34627910)
24. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Res. 1995;27:57-63.
25. Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1997;38:2586-2596. (Pubitemid 27492761)
26. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2638-2651. (Pubitemid 29455495)
27. Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci. 2004;45:1002-1008. (Pubitemid 38868404)
28. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102:783-791. (Pubitemid 28399611)
29. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336. (Pubitemid 39121873)
30. Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci. 2008;49:732-742.
31. Nakazawa T, Sato A, Mori A, Saito M, Sakamoto K, Nakahara T, et al. β-Adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats. Vascular Pharmacol. 2008;49:77-83.
32. Kametaka S, Kasahara T, Ueo M, Takenaka M, Saito M, Sakamoto K, et al. A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats. J Pharmacol Sci. 2008;106:144-151. (Pubitemid 351159080)